Antiviral therapy for genital herpes in nonpregnant and pregnant women

International Journal of Fertility and Women's Medicine

Volumn 43, Issue 5, 1998, Pages 243-248

  Baker, David A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Antiviral therapy; Genital herpes; Viral STDs

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; VALACICLOVIR;

ANTIVIRAL ACTIVITY; DIAGNOSTIC APPROACH ROUTE; DRUG CHOICE; GENITAL HERPES; HERPES SIMPLEX VIRUS; INFECTION PREVENTION; NEWBORN INFECTION; PLACENTAL TRANSFER; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; REINFECTION; REVIEW; SEROPREVALENCE; SEXUAL TRANSMISSION; VIRUS REPLICATION; VIRUS SHEDDING;

2-AMINOPURINE; ACYCLOVIR; ANTIVIRAL AGENTS; FEMALE; HERPES GENITALIS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VALINE;

EID: 0031770264     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Johnson RE, Nahmias AJ, Magder LS, et al: A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 32:7-12, 1989.
2. Benedetti J, Corey L, Ashley R: Recurrence rate in genital herpes after symptomatic first-episode infection. Ann Intern Med 121:847-854, 1994.
3. Koelle DM, Benedetti J, Langenberg A, et al: Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 116:433-437, 1992.
4. Bryson Y, Dillon M, Bernstein DI, et al: Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: A prospective couple study. J Infect Dis 167:942-946, 1993.
5. Mertz GJ, Benedetti J, Ashley R, et al: Risk factors for the sexual transmission of genital herpes. Ann Intern Med 116:197-202, 1992.
6. Hirsch MS: Herpes simplex virus, in Mandell JE, Dolin R (eds): Principles and Practice of Infectious Diseases,. 4th ed. New York, Churchill Livingstone, pp 1336-1345, 1995.
7. Koelle DM, Benedetti J, Langenberg A, et al: Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Int Med 116:433-437, 1992.
8. Wald A, Zeh J, Selke S, et al: Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 333:771-775, 1995.
9. Koutsky LA, Stevens CE, Holmes KK, et al: Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 326:1533-1539, 1992.
10. Woods GL: Update on laboratory diagnosis of sexually transmitted diseases. Clin Lab Med 15:665- 684, 1995.
11. Ashley RL: Laboratory techniques in the diagnosis of herpes simplex infection.
12. Lavoie SL, Kaplowitz LG: Management of genital herpes infections. Semin Dermatol 13:248-255, 1994.
13. Wald A, Zeh J, Barnum G, et al: Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 124 (1, pt 1):8-15, 1996.
14. Mertz GL, Loveless MA, Kraus SJ, et al: Famciclovir for the suppression of recurrent genital herpes. Proceedings of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, American Society for Microbiology, 1994 (Abstract H3).
15. Sarag P, Chastong C, Bertin I, et al: Efficacy and safety equivalence of 1,000 mg once daily and 500 mg twice daily valaciclovir in recurrent genital herpes. Proceedings 36th ICAAC, New Orleans, ASM, 1996 (Abstract H113).
16. Baker DA and the Valacyclovir Study Group: Once daily valacyclovir for suppression of recurrent genital herpes in patients previously receiving 10 years of twice daily acyclovir suppressive therapy. Annual Clinical Meeting, ACOG, 1997.
17. Goldberg LH, Kaufman R, Kurtz TO, et al: Long-term suppression of recurrent genital herpes with acyclovir. Arch Dermatol 129:582-587, 1993.
18. Fife KH, Crumpacker CS, Mertz GJ, Hill EI, Boone GS, and the Acyclovir Study Group: Recurrence and resistance patterns of herpes simplex virus following cessation of ≥6 years of chronic suppression with acyclovir. J Infect Dis 169:1338-1341, 1994.
19. Patel R, Crooks JR, Bell AR, and the International Valacyclovir Study Group: Once-daily valacyclovir for the suppression of recurrent genital herpes - the first placebo controlled clinical trial. Presented at the First European Congress of Chemotherapy, Glasgow, UK, 1996.
20. Dracker JL, Miller JM, and The International Valacyclovir Study Group: Once-daily valacyclovir sustains the suppressive efficacy and safety record of acyclovir in recurrent genital herpes. First European Congress of Chemotherapy, Glasgow, UK, 1996 (Abstract).
21. Centers for Disease Control: Pregnancy outcomes following systemic acyclovir exposure, June 1, 1984-June 30, 1993. MMWR 42:806-809, 1993.
22. Scott LL, Sanchez PJ, Jackson GL, et al: Acyclovir suppression to prevent cesarean delivery after first episode genital herpes. Obstet Gynecol 87:69-73, 1996.